Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
Journal of Forensic Sciences
|
March 5, 2020
The 2018 California Wildfires: Integration of Rapid DNA to Dramatically Accelerate Victim Identification
Kim Gin, Jason Tovar, Eric J Bartelink, et al.
Journal of Synchrotron Radiation
|
June 2, 2025
Design and commissioning of the first superconducting undulator for the BioSAXS beamline at the Australian Synchrotron
Yaw Ren Eugene Tan, Sina Porsa, David Zhu, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors
Vincent A de Weger, Sanjay Goel, Roger von Moos, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trial
Apostolia-Maria Tsimberidou, Chris H M Takimoto, Stacy Moulder, et al.
Frontiers in Oncology
|
August 8, 2020
The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data
Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
Investigational New Drugs
|
August 25, 2012
Metabolism of patupilone in patients with advanced solid tumor malignancies
Kevin R Kelly, Markus Zollinger, Frédéric Lozac'h, et al.
Plos One
|
June 1, 2017
Rapid detection and strain typing of Chlamydia trachomatis using a highly multiplexed microfluidic PCR assay
Rosemary S Turingan, Ludmila Kaplun, Greice Krautz-Peterson, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2019
Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance
Chaobin Jin, Rawaf Alenazy, Yinhu Wang, et al.
Molecular Oncology
|
August 9, 2014
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial
Miguel Quintela-Fandino, Maria J Bueno, Luis Lombardia, et al.
NPJ Breast Cancer
|
March 23, 2021
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data
Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
Journal of Forensic Sciences
|
March 5, 2020
The 2018 California Wildfires: Integration of Rapid DNA to Dramatically Accelerate Victim Identification
Kim Gin, Jason Tovar, Eric J Bartelink, et al.
Journal of Synchrotron Radiation
|
June 2, 2025
Design and commissioning of the first superconducting undulator for the BioSAXS beamline at the Australian Synchrotron
Yaw Ren Eugene Tan, Sina Porsa, David Zhu, et al.
Cancer Chemotherapy and Pharmacology
|
November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors
Vincent A de Weger, Sanjay Goel, Roger von Moos, et al.
Molecular Cancer Therapeutics
|
January 12, 2011
Effects of patupilone on the pharmacokinetics and pharmacodynamics of warfarin in patients with advanced malignancies: a phase I clinical trial
Apostolia-Maria Tsimberidou, Chris H M Takimoto, Stacy Moulder, et al.
Frontiers in Oncology
|
August 8, 2020
The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data
Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
Investigational New Drugs
|
August 25, 2012
Metabolism of patupilone in patients with advanced solid tumor malignancies
Kevin R Kelly, Markus Zollinger, Frédéric Lozac'h, et al.
Plos One
|
June 1, 2017
Rapid detection and strain typing of Chlamydia trachomatis using a highly multiplexed microfluidic PCR assay
Rosemary S Turingan, Ludmila Kaplun, Greice Krautz-Peterson, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 14, 2019
Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance
Chaobin Jin, Rawaf Alenazy, Yinhu Wang, et al.
Molecular Oncology
|
August 9, 2014
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial
Miguel Quintela-Fandino, Maria J Bueno, Luis Lombardia, et al.
NPJ Breast Cancer
|
March 23, 2021
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data
Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
Page
of 10